Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001683168-16-000925
Filing Date
2016-12-13
Accepted
2016-12-13 13:56:09
Documents
49
Period of Report
2016-08-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K cannabics_10k-083116.htm 10-K 367814
2 CERTIFICATION cannabics_10k-ex3101.htm EX-31.1 11707
3 CERTIFICATION cannabics_10k-ex3102.htm EX-31.2 11629
4 CERTIFICATION cannabics_10k-ex3201.htm EX-32.1 4384
5 CERTIFICATION cannabics_10k-ex3202.htm EX-32.2 4527
  Complete submission text file 0001683168-16-000925.txt   1919134

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE cnbx-20160831.xml EX-101.INS 271846
7 XBRL SCHEMA FILE cnbx-20160831.xsd EX-101.SCH 22112
8 XBRL CALCULATION FILE cnbx-20160831_cal.xml EX-101.CAL 32165
9 XBRL DEFINITION FILE cnbx-20160831_def.xml EX-101.DEF 69767
10 XBRL LABEL FILE cnbx-20160831_lab.xml EX-101.LAB 164641
11 XBRL PRESENTATION FILE cnbx-20160831_pre.xml EX-101.PRE 134423
Mailing Address #3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814
Business Address #3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814 877-424-2429
Cannabics Pharmaceuticals Inc. (Filer) CIK: 0001343009 (see all company filings)

EIN.: 203373669 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-52403 | Film No.: 162048483
SIC: 2834 Pharmaceutical Preparations